Dr. Dennis Metzger, professor and chair of the Department of Immunology and Microbial Disease at Albany Medical College, was recently appointed to the National Science Advisory Board for Biosecurity. Biosecurity is defined as procedures intended to protect humans or animals against disease or harmful biological agents. Given the pandemic, it's clear that Metzger is in the middle of the action.
RSV is a common respiratory virus that usually causes mild, cold-like symptoms. Most people recover in a week or two, but it can cause severe illness. Earlier in June, the CDC issued a warning that cases of RSV were climbing in the southern states. So what do we in the northeast need to know about RSV?
Aging and dementia. Just because we get old doesn't mean cognitive decline is inevitable. In fact, that's a misconception too many of us have – including medical professionals. AARP has a new study out on this.
The pandemic is pretty much behind us in New York, but the after effects linger. One of the issues is a continuing shortage of donated blood. As we move into the summer months, when demand often increases, that has folks at the Red Cross very worried.
The controversy of a newly approved Alzheimer’s drug not only hasn't settled down. Three members of the FDA quit over it. So what does that mean for people diagnosed with the disease? How can family members make decisions?
As the delta variant of the COVID-19 virus continues to span the globe, now there’s a super delta variant. What does that mean and will the current vaccines protect against it? Dr. Eli Rosenberg, associate professor of epidemiology at UAlbany is my guest.
Long haulers is the term for people who continue suffering symptoms even after they recover from COVID-19. Little-known illnesses are being diagnosed in a growing number of these folks. What does that mean for their health? How to get diagnosed properly and treated? And what are the implications for health care?
As vaccination rates against COVID-19 begin to taper off, the delta variant of the coronavirus is increasing and it's a more easily transmissible variant. So what does this hold for us? Dr. David Holtgrave, the dean of the School of Public Health at the University at Albany, recently penned an op-ed piece on this and joins me to discuss it.
Light sensitivity, or photophobia, is a frequent symptom of migraine headaches, which affect nearly 15% of the world's population. Now imagine a specific light therapy could tame those headaches. Green light therapy is being heralded as helping and Dr. Stephen Silberstein, director of the Headache Center at Jefferson University in Philadelphia, is my guest to discuss this.
The emotional trauma of the past year has affected so many of us – exacerbating existing mental health issues and triggering new ones. David Rosetti, chief officer of behavioral health for Northern Rivers family of services, is here to discuss the support it's offering – empowering children, adults, and families to change their lives and build stronger communities.
